Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ISRG
Valuation Bad
0%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 16.72 5.55 4.76
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -5.76 -4.91 -4.64
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 4.51 39.50 37.79
Cash -8.46 13.58 14.83
Capex 44.67 -0.68 -1.24
Free Cash Flow 2.37 -0.57 -0.59
Revenue -2.34 5.35 5.48
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -0.56 0.66 0.66
Operating Margin 6.34 0.25 0.23
ROA -12.31 0.03 0.04
ROE -14.33 0.04 0.05
ROIC -12.28 0.04 0.04
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ISRG is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ISRG is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ISRG is permitted for members.